These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis]. Takezaki M, Ishida Y, Morozumi T, Tani A, Sato H, Hori M, Kitabatake A, Kamada T, Kimura K, Kozuka T. Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088 [Abstract] [Full Text] [Related]
5. Abnormal scintigraphic evolution in AA hepatic amyloidosis. Lomeña F, Roselló R, Pons F, Grau M, García A, Catafau A, Setoain J. Clin Nucl Med; 1988 Mar; 13(3):194-6. PubMed ID: 2838214 [Abstract] [Full Text] [Related]
13. [Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy]. Hongo M, Misawa T, Yamada H, Hirayama J, Okubo S, Fujii T, Kusama S, Ikeda S. Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):1-8. PubMed ID: 3009667 [No Abstract] [Full Text] [Related]
14. [A case of familial amyloid polyneuropathy demonstrating marked myocardial uptake of technetium-99m-pyrophosphate]. Kawashima A, Hongo M, Matsuoka K, Soga N, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S. Nihon Naika Gakkai Zasshi; 1985 Jun; 74(6):774-9. PubMed ID: 2995520 [No Abstract] [Full Text] [Related]
15. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis]. Volpi A, Cavalli A, Maggioni AP, Inglese E, Rovelli GE, Neri R, Salvi A. G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892 [Abstract] [Full Text] [Related]